Can you update the discharge instructions for a 13‑year‑old male with Henoch‑Schönlein purpura who was started on cefuroxime and switched to co‑amoxiclav (amoxicillin + clavulanic acid) on day 3, now on day 2 of co‑amoxiclav?

Discharge Instructions for a 13-Year-Old with Henoch-Schönlein Purpura After Antibiotic Switch

Continue co-amoxiclav at the current dose for a total duration of 7–10 days from the start of antibiotic therapy (counting from day 1 of cefuroxime), ensuring adequate coverage of the presumed bacterial infection that prompted initial treatment. 1

Antibiotic Management

Current Regimen

• Complete the full course of co-amoxiclav (amoxicillin-clavulanate) as prescribed, which should total 7–10 days of antibiotic therapy when combined with the initial 3 days of cefuroxime 1
• For a 13-year-old, the typical dose is 5 ml of 250/62 suspension three times daily or one 250/125 tablet three times daily, depending on weight and severity 2
• Do not stop antibiotics early even if symptoms improve, as incomplete courses promote resistance and increase relapse risk 1

Rationale for the Switch

• Co-amoxiclav was appropriately chosen after 3 days of cefuroxime, as amoxicillin-clavulanate provides superior early symptom resolution and lower relapse rates compared to cefuroxime for respiratory and sinus infections 1
• The switch addresses potential β-lactamase-producing organisms (H. influenzae, M. catarrhalis) that may not respond adequately to cefuroxime alone 1, 2

Expected Clinical Response

• Clinical improvement should be evident within 48–72 hours of starting co-amoxiclav (now day 2 of this regimen) 2
• If fever, pain, or other symptoms worsen or fail to improve by day 4–5 of total antibiotic therapy, return immediately for reassessment and consideration of alternative diagnoses or complications 1

Henoch-Schönlein Purpura (IgA Vasculitis) Monitoring

Disease Course and Prognosis

• HSP spontaneously resolves in 94% of children, making supportive care the primary management strategy 3, 4
• The condition typically improves over 2–4 weeks, though relapses occur in up to 30% of cases within the first 6 months 3

Critical Warning Signs Requiring Immediate Medical Attention

• Severe abdominal pain, bloody stools, or persistent vomiting (may indicate gastrointestinal complications including intussusception or bleeding) 5, 6, 4
• Decreased urine output, blood in urine, or significant facial/leg swelling (suggests worsening renal involvement) 3, 4
• Severe headache, altered mental status, or seizures (rare CNS complications) 3
• Testicular pain or swelling in males (orchitis complication) 3

Renal Monitoring Protocol

• Obtain urinalysis and blood pressure measurement weekly for the first month, then monthly for 6 months 3, 4
• 40–50% of children with HSP develop some degree of renal involvement, ranging from microscopic hematuria to nephritic syndrome 4
• Long-term prognosis depends entirely on the extent of renal disease; end-stage renal disease occurs in 1–5% of patients 4
• Six months of follow-up is mandatory to assess for disease relapse or progression to chronic kidney disease 3

Supportive Care Measures

Pain and Inflammation Management

• Acetaminophen (paracetamol) 15 mg/kg every 4–6 hours for joint pain and fever (maximum 75 mg/kg/day or 4 g/day) 3, 4
• Avoid NSAIDs (ibuprofen, naproxen) during active disease, as they may worsen gastrointestinal symptoms and mask renal complications 3
• Rest and elevate affected limbs to reduce purpura and joint swelling 4

Corticosteroid Use

• Steroids are NOT indicated prophylactically and do not prevent renal or other complications in uncomplicated HSP 3
• Oral prednisone 1–2 mg/kg/day for 2 weeks may be considered only if severe abdominal pain or joint symptoms persist despite supportive care 4
• High-dose steroids plus immunosuppressants are reserved for severe renal involvement (nephrotic syndrome, rapidly progressive glomerulonephritis) and require specialist management 3, 4

Activity and Diet Recommendations

• Resume normal activities gradually as tolerated, but avoid strenuous exercise until purpura and joint symptoms fully resolve 4
• Maintain adequate hydration (1.5–2 liters/day for a 13-year-old) to support renal function 3
• No dietary restrictions are necessary unless specific food triggers were identified, though some clinicians recommend avoiding potential allergens during the acute phase 7

Follow-Up Schedule

Immediate Follow-Up (Within 3–5 Days)

• Reassess antibiotic response and ensure clinical improvement of the infection that prompted initial treatment 1
• Check blood pressure and urinalysis to establish baseline renal status 3, 4

Short-Term Follow-Up (Weekly for 1 Month)

• Weekly urinalysis and blood pressure checks to detect early renal involvement 3, 4
• Monitor for disease relapse (recurrence of purpura, abdominal pain, or joint symptoms) 3

Long-Term Follow-Up (Monthly for 6 Months)

• Monthly urinalysis and blood pressure to identify late-onset or progressive renal disease 3, 4
• Nephrology referral if persistent hematuria, proteinuria, hypertension, or declining renal function develops 3, 4

Common Pitfalls to Avoid

• Do not assume HSP is "just a rash"—renal involvement can be silent initially and progress insidiously over months 3, 4
• Do not discontinue renal monitoring at 1 month even if initial tests are normal; late renal complications can emerge up to 6 months after presentation 3
• Do not prescribe prophylactic steroids in the absence of severe symptoms, as they do not prevent complications and carry unnecessary risks 3
• Do not ignore persistent or worsening abdominal pain—this may indicate intussusception, bowel perforation, or other surgical emergencies requiring imaging 5, 6